Nanjing Heron Pharmaceutical Science & Technology

Nanjing Heron Pharmaceutical Science & Technology is a leading Chinese pharmaceutical company dedicated to the development and commercialization of high-barrier generic drugs and innovative medicines. Founded in 2013 and based in Nanjing, the company specializes in complex formulations and difficult-to-synthesize active pharmaceutical ingredients, particularly in the fields of anticoagulation, anesthesia, and nephrology. Their commercial success is driven by key products such as Fondaparinux Sodium and Sugammadex Sodium, which address significant unmet needs in the domestic market. Heron Pharma utilizes advanced technology platforms for complex injections and polymer-based drugs to maintain a competitive edge. The company's robust pipeline includes several late-stage candidates targeting hyperkalemia and epilepsy, reflecting its commitment to expanding its therapeutic footprint.